StonvexLoading…
StonvexStonvexStonvexCore line items from AMPG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $5.35M | $25.20M | $20.72M | $14.63M |
Operating Income | $-1.62M | $-7.32M | $-4.04M | $-3.82M |
Net Income | $-1.52M | $-7.01M | $-3.80M | $-3.61M |
EPS (Diluted) | $-0.06 | $-0.33 | $-0.19 | $-0.18 |
Total Assets | $59.74M | $51.48M | $47.24M | $48.64M |
Total Liabilities | $11.38M | $18.62M | $11.42M | $12.83M |
Cash & Equivalents | $11.81M | $4.98M | $8.39M | $11.06M |
Free Cash Flow OCF − CapEx | Not available | $-9.70M | $-6.19M | $-4.75M |
Shares Outstanding | 25.34M | 20.68M | 20.63M | 20.57M |